WARSAW — Zimmer Biomet Holdings Inc., a global leader in musculoskeletal healthcare, announced today, Monday, Aug. 15, the acquisition of CD Diagnostics, a fully integrated, Delaware-based diagnostics company focused on developing immunoassays and biomarker testing to inform treatment decisions that improve patient outcomes. The financial terms of the transaction were not disclosed. Zimmer Biomet and …read more.